Mode
Text Size
Log in / Sign up

glucagon

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of glucagon

14 trials tracked of glucagon: 3 in phase 3 or 4.

14Trials tracked
3Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 5 Phase 1 4 Other / NA 2
  1. Phase 4 Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon Completed
  2. Phase 4 Glucagon Use in Colonoscopies Completed
  3. Phase 3 Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients Completed
  4. Phase 2 CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism Completed
  5. Phase 2 G-Pen™ for Hypoglycemia Rescue in T1D Patients Completed
  6. Phase 2 Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone Completed
Show 8 more trials
  1. Phase 2 Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia Completed
  2. Phase 2 Feasibility Trial Testing the Bionic Pancreas With ZP4207 Completed
  3. Phase 1 The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA Completed
  4. Phase 1 Study of LY2409021 in Participants With Type 1 Diabetes Completed
  5. Phase 1 Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose Completed
  6. Phase 1 A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults Completed
  7. N/A Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver Completed
  8. N/A Physiologic Response to Glucagon at Varying Insulin Levels Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.